Gastric Perforation and Death after the Insertion of an Intragastric Balloon

Koutelidakis, Ioannis; Dragoumis, Dimitrios; Papaziogas, B.; Patsas, A.; Katsougianopoulos, Alexandros; Atmatzidis, Stefanos; Atmatzidis, Konstantinos

doi:10.1007/s11695-008-9706-5

Cited by 32 publications

(21 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The balloon was implanted 6 and 9 months, respectively, before symptoms appeared. Gastric perforations with death after insertion of gastric balloon device were reported by Koutelidakis et al [14] and Genco et al [6] and after balloon removal by Ponzo et al [15]. In another case of gastric perforation 2 months following gastric balloon insertion [16], the patient survived after laparotomy and closure of a large linear perforation.…”

Section: Discussionmentioning

confidence: 89%

Mechanical Ileus Induces Surgical Intervention Due to Gastric Balloon: A Case Report and Review of the Literature

et al. 2010

View full text Add to dashboard Cite

A temporary non-surgical approach for treatment of obesity is the gastric balloon that serves as an alternative procedure for many patients with frustrated diet attempts. Deflation and displacement of the balloon resulting in acute intestinal obstruction and subsequent surgical intervention is a rare complication. A BioEnterics Intragastric Balloon was endoscopically implanted in a 35-year-old female with a body mass index (BMI) of 28 kg/m(2). The procedure succeeded without complications, and weight loss was effective during the first 6 months. One year after balloon implantation, the patient presented with abdominal cramps and vomiting due to ileal obstruction. Since endoscopic efforts to remove the deflated and displaced balloon failed, emergency laparotomy and enterotomy were necessary. Vascularization of the dilated small bowel was compromised, but recovered after decompression. Patients' postoperative course was uneventful. The gastric balloon model can be associated with major complications and should be used critically. Removal of the balloon should be assured not later than 6 months when weight loss decreases.

show abstract

Section: Discussionmentioning

confidence: 89%

Mechanical Ileus Induces Surgical Intervention Due to Gastric Balloon: A Case Report and Review of the Literature

et al. 2010

View full text Add to dashboard Cite

show abstract

“…There were reports of rare and serious complications such as gastric perforation [15], small intestinal obstruction [16,17], small bowel necrosis [18], and acute pancreatitis [19,20]. There were also descriptions of fatal complications in the course of intragastric balloon treatment [21,22,23]. …”

Section: Discussionmentioning

confidence: 99%

Gastric Ulcer Hemorrhage - a Potential Life-Threatening Complication of Intragastric Balloon Treatment of Obesity

Mojkowska¹,

Gaździński²,

Frączek³

et al. 2017

Obes Facts

View full text Add to dashboard Cite

Background: Some morbidly obese patients do not qualify for bariatric surgery due to general health contraindications. Intragastric balloon treatment might be a therapeutic option in the above-mentioned cases. It can prime super-obese patients with end-stage disease for bariatric surgery. As a neoadjuvant therapy before surgery, it leads to a downstage of the disease by preliminary weight reduction, to an improvement in general health and, in summary, to a reduction of the perioperative risk. It is generally considered to be a safe method. However, due to the wide range of possible complications and unusual symptoms after intragastric balloon treatment, an interdisciplinary, instead of only a surgical or endoscopic, treatment and follow-up might be recommended in these patients. Case Report: We here describe a potential life-threatening complication in the form of gastric bleeding as a consequence of intragastric balloon treatment and simultaneous aspirin taking and Helicobacter pylori infection. Conclusion: There have been reports of some complications of intragastric balloon treatment. However, to the best of our knowledge there were no reports concerning life-threatening hemorrhage from gastric ulcer.

show abstract

“…Research was inspired by the discovery that people with gastric bezoars constantly intake limited amounts of food [1,5]. The IGB was initially designed to maintain weight loss in patients who do not respond to conservative therapy but are not yet candidates for surgical intervention [6,10]. The IGB system involves distension of the stomach, which subsequently induces a feeling of early satiety and leads to weight loss [9].…”

Section: Discussionmentioning

confidence: 99%

“…In 1 patient, the IGB was spontaneously deployed via the feces and was replaced with a new one in an outpatient fashion. The latter is one of the features of IGB treatment since it can be re-applied to the same patient repeatedly with an acceptable complication rate [4,6].…”

Section: Discussionmentioning

confidence: 99%

“…Genco et al [16] stated that sleeve gastrectomy or IGB treatment 12 type is most commonly used, and was also used in our study. It has many merits such as outpatient application, reversibility, re-applicability, lower rates of gastrointestinal and systemic complications, and decreased food consummation [1,4,6,10,11]. The IGB has been also used as preparation for major surgical procedures to minimize anesthesia risk [6], and it has been indicated that it can be safely applied in morbidly obese patients before bariatric procedures to decrease morbidity and mortality following definitive surgery [12,13].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Intragastric Balloon Treatment for Obesity: Prospective Single-Center Study Findings

Peker

Durak

Özgürbüz³

2010

Obes Facts

View full text Add to dashboard Cite

Background: The intragastric balloon (IGB) procedure is an obesity treatment. Methods: A BioEnteric IGB was used in 33 patients between February 2006 and February 2009. Results: Of the 31 patients, 19 were female (61.3%). Mean age was 35.48 ± 9.31 years. Following intravenous sedation, the balloon was inserted and inflated under direct vision by using saline (600 ml) and methylene blue (10 ml) solution. Average weight and mean BMI scores were as follows: 119.34 ± 22.64 (range 80–170) kg and 41.84 ± 8.28 (range 30–63.2) kg/m². Mean weight and BMI were measured as 104.31 ± 21.33 (range 64–151) kg and 36.43 ± 7.36 (range 26–52) kg/m² 6 months after the index procedure. Percent of excess weight loss (%EWL) and percent of excess body mass index loss (%EBMIL) were as follows: 29.16 ± 15.99% (range 0.00–56.91%) and 35.45 ± 19.46% (0–75.2%), respectively. All patients lost weight constantly for the 6-month period. Patients showed statistically significant weight and BMI losses for the first 3-month period but these decrements reached a plateau between the 4th and 6th month. Weight loss was not statistically significant during the second 3-month period. Few patients had mild complaints following balloon insertion; there was no balloon intolerance. Conclusions: IGB is safe and effective for short-term weight reduction in obese patients. Weight reduction during the second half of the treatment period needs closer follow-up.

show abstract

Gastric Perforation and Death after the Insertion of an Intragastric Balloon

Cited by 32 publications

References 13 publications

Mechanical Ileus Induces Surgical Intervention Due to Gastric Balloon: A Case Report and Review of the Literature

Mechanical Ileus Induces Surgical Intervention Due to Gastric Balloon: A Case Report and Review of the Literature

Gastric Ulcer Hemorrhage - a Potential Life-Threatening Complication of Intragastric Balloon Treatment of Obesity

Intragastric Balloon Treatment for Obesity: Prospective Single-Center Study Findings

Contact Info

Product

Resources

About